Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Comparison of MGUS and multiple myeloma variants | Download Table
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance | Bone Marrow Transplantation
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance | NEJM
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study - Clinical Lymphoma, Myeloma and Leukemia
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Monoclonal gammopathy of renal significance: Early diagnosis is key - ScienceDirect
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Monoclonal Gammopathy–Associated Peripheral Neuropathy: Diagnosis and Management - Mayo Clinic Proceedings
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance | NEJM
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Prevalence of Monoclonal Gammopathy of Undetermined Significance | NEJM
Multiple Myeloma: Diagnosis and Treatment | AAFP
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
Renal Manifestations of Plasma Cell Disorders - American Journal of Kidney Diseases
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
